UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Periaqueductal Gray Matter Dysfunction in Migraine: Cause or the Burden of Illness?

Headache, 2001-07, Vol.41 (7), p.629-637

2001

Volltextzugriff (PDF)

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

Cephalalgia, 2010-07, Vol.30 (7), p.804-814

2010

Volltextzugriff (PDF)

The Brain is Hyperexcitable in Migraine

Cephalalgia, 2007-12, Vol.27 (12), p.1442-1453

2007

Volltextzugriff (PDF)

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

Cephalalgia, 2010-07, Vol.30 (7), p.793-803

2010

Volltextzugriff (PDF)

Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study

Neurology, 2003-02, Vol.60 (4), p.630

2003

Volltextzugriff (PDF)

A Real‐World Analysis of Migraine: A Cross‐Sectional Study of Disease Burden and Treatment Patterns

Headache, 2017-11, Vol.57 (10), p.1532-1544

2017

Volltextzugriff (PDF)

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

Headache, 2010-06, Vol.50 (6), p.921-936

2010

Volltextzugriff (PDF)

Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

Lancet neurology, 2010-04, Vol.9 (4), p.373-380

2010

Volltextzugriff (PDF)

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program

Acta neurologica Scandinavica, 2014-01, Vol.129 (1), p.61-70

2014

Volltextzugriff (PDF)

The Occipital Cortex Is Hyperexcitable in Migraine: Experimental Evidence

Headache, 1999-07, Vol.39 (7), p.469-476

1999

Volltextzugriff (PDF)

Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in U.S. Healthcare Claims Data

Headache, 2017-10, Vol.57 (9), p.1359-1374

2017

Volltextzugriff (PDF)

Is Chronic Migraine One End of a Spectrum of Migraine or a Separate Entity?

Cephalalgia, 2009-06, Vol.29 (6), p.597-605

Aurora, SK

2009

Volltextzugriff (PDF)

Functional MRI-BOLD of brainstem structures during visually triggered migraine

Neurology, 2002-07, Vol.59 (1), p.72

2002

Volltextzugriff (PDF)

Health Care Utilization and Direct Costs Among Patients Diagnosed with Cluster Headache in U.S. Health Care Claims Data

Journal of managed care & specialty pharmacy, 2018-09, Vol.24 (9), p.921

2018

Volltextzugriff (PDF)

Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine

Patient preference and adherence, 2018-01, Vol.12, p.2413-2424

2018

Volltextzugriff (PDF)

PND44 - Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients with Migraine: Results from Two Global Phase 3 Clinical Trials

Value in health, 2018-05, Vol.21, p.S208-S209

2018

Volltextzugriff (PDF)

Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients with Migraine: Results from Two Global Phase 3 Clinical Trials

Value in health, 2018-05, Vol.21, p.S208-S209

2018

Volltextzugriff (PDF)

Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease

Headache, 2012-02, Vol.52 (2), p.224-235

2012

Volltextzugriff (PDF)

Magnetoencephalographic fields from patients with spontaneous and induced migraine aura

Annals of neurology, 2001-11, Vol.50 (5), p.582-587

2001

Volltextzugriff (PDF)

Gastric Stasis in Migraine: More Than Just a Paroxysmal Abnormality During a Migraine Attack

Headache, 2006-01, Vol.46 (1), p.57-63

2006

Volltextzugriff (PDF)

Cortical Inhibition Is Reduced in Chronic and Episodic Migraine and Demonstrates a Spectrum of Illness

Headache, 2005-05, Vol.45 (5), p.546-552

2005

Volltextzugriff (PDF)

The Threshold for Phosphenes is Lower in Migraine

Cephalalgia, 2003-05, Vol.23 (4), p.258-263

2003

Volltextzugriff (PDF)

Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine

Neurology, 1998-04, Vol.50 (4), p.1111

1998

Volltextzugriff (PDF)

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT: Doc 535

Journal of headache and pain, 2013-02, Vol.14, p.1

2013

Volltextzugriff (PDF)

Topiramate modulates excitability of the occipital cortex when measured by transcranial magnetic stimulation

Cephalalgia, 2010-06, Vol.30 (6), p.648-654

2010

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(52)
Buchkapitel
(2)

Sprache

Englisch
(54)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(43)
Science & Technology
(43)
Humans
(34)
Clinical Neurology
(31)
Neurosciences & Neurology
(31)
Male
(24)
Adult
(21)
Female
(20)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Middle Aged
(16)
Migraine Disorders - Physiopathology
(15)
Neurology
(15)
Migraine
(14)
Neurosciences
(14)
Vascular Diseases And Vascular Malformations Of The Nervous System
(10)
Adolescent
(8)
Aged
(8)
Pharmacology. Drug Treatments
(8)
Transcranial Magnetic Stimulation
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Periaqueductal Gray Matter Dysfunction in Migraine: Cause or the Burden of Illness?

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

The Brain is Hyperexcitable in Migraine

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study

A Real‐World Analysis of Migraine: A Cross‐Sectional Study of Disease Burden and Treatment Patterns

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program

The Occipital Cortex Is Hyperexcitable in Migraine: Experimental Evidence

Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in U.S. Healthcare Claims Data

Is Chronic Migraine One End of a Spectrum of Migraine or a Separate Entity?

Functional MRI-BOLD of brainstem structures during visually triggered migraine

Health Care Utilization and Direct Costs Among Patients Diagnosed with Cluster Headache in U.S. Health Care Claims Data

Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine

PND44 - Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients with Migraine: Results from Two Global Phase 3 Clinical Trials

Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients with Migraine: Results from Two Global Phase 3 Clinical Trials

Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease

Magnetoencephalographic fields from patients with spontaneous and induced migraine aura

Gastric Stasis in Migraine: More Than Just a Paroxysmal Abnormality During a Migraine Attack

Cortical Inhibition Is Reduced in Chronic and Episodic Migraine and Demonstrates a Spectrum of Illness

The Threshold for Phosphenes is Lower in Migraine

Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT: Doc 535

Topiramate modulates excitability of the occipital cortex when measured by transcranial magnetic stimulation

Suchergebnisse filtern